ICU Medical, Inc.
ICUI
$148.44
-$0.70-0.47%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -8.85% | -7.98% | 6.71% | 7.14% | 6.47% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -8.85% | -7.98% | 6.71% | 7.14% | 6.47% |
| Cost of Revenue | -12.54% | -12.40% | 3.46% | -3.30% | 4.03% |
| Gross Profit | -1.94% | 0.31% | 13.42% | 32.45% | 11.38% |
| SG&A Expenses | -6.11% | -0.10% | -0.27% | 2.74% | 9.49% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.19% | -8.73% | 2.53% | -1.61% | 5.41% |
| Operating Income | 27.18% | 9.46% | 414.97% | 946.11% | 46.23% |
| Income Before Tax | 77.39% | 286.95% | 70.34% | 122.40% | -234.10% |
| Income Tax Expenses | -104.37% | -37.11% | 69.07% | 264.05% | 219.45% |
| Earnings from Continuing Operations | 89.70% | 265.08% | 60.79% | -38.96% | -555.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 89.70% | 265.08% | 60.79% | -38.96% | -555.69% |
| EBIT | 27.18% | 9.46% | 414.97% | 946.11% | 46.23% |
| EBITDA | 1.13% | -4.18% | 28.98% | 91.52% | 5.47% |
| EPS Basic | 89.81% | 263.41% | 61.30% | -36.97% | -550.05% |
| Normalized Basic EPS | 251.54% | 495.03% | 128.79% | 144.51% | 63.37% |
| EPS Diluted | 89.63% | 262.50% | 61.31% | -38.15% | -550.15% |
| Normalized Diluted EPS | 251.54% | 494.03% | 128.79% | 144.51% | 63.00% |
| Average Basic Shares Outstanding | 1.01% | 1.03% | 1.31% | 1.46% | 1.27% |
| Average Diluted Shares Outstanding | 1.01% | 1.29% | 1.31% | 1.46% | 0.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |